Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2019.
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2019.
复制标题
DOI：
10.4143/crt.2022.128
复制
发表时间：
2022-04
影响因子：
4.6
通讯作者：
Seo, Hong Gwan
中科院分区：
文献类型：
--
作者：
Kang, Mee Joo;Won, Young-Joo;Lee, Jae Jun;Jung, Kyu-Won;Kim, Hye-Jin;Kong, Hyun-Joo;Im, Jeong-Soo;Seo, Hong Gwan
目前的研究提供了韩国的国家癌症统计数据及其长期趋势，包括2019年的发病率、死亡率、生存率和患病率。1999年至2019年，使用韩国国家癌症发病率数据库计算癌症的发病率、生存率和患病率，并随访至2020年12月31日。使用从韩国统计局获得的死亡原因数据评估癌症死亡。2019年，新诊断的癌症病例和癌症死亡人数分别为254,718例（年龄标准化率[ASR]，每10万人275.4例）和81,203例（ASR，每10万人72.2例）。除甲状腺癌外，肺癌（29960名）的发病率首次超过了其他癌症。总体癌症发病率从1999年到2012年每年增长3.3%，从2012年到2015年每年下降5.3%，此后变化不显著。甲状腺癌的发病率从2016年开始再次上升（年变化百分比为6.2%）。自2002年以来，癌症死亡率一直在下降，近年来下降速度更快（2002年至2013年每年下降2.7%；2013年至2019年每年下降3.3%）。2015年至2019年的5年相对生存率为70.7%，这导致2019年流行病例超过200万例。在过去的几十年里，癌症存活率有所提高，但新诊断出的癌症数量仍在增加，有些癌症的生存结果仅略有改善。随着癌症幸存者人数的增加，应根据癌症统计数据的变化实施全面的癌症控制战略。
The current study provides national cancer statistics and their secular trends in Korea, including incidence, mortality, survival, and prevalence in 2019. Incidence, survival, and prevalence rates of cancer were calculated using the Korea National Cancer Incidence Database, from 1999 to 2019, with survival follow-up until December 31, 2020. Deaths from cancer were assessed using causes-of-death data obtained from Statistics Korea. In 2019, newly diagnosed cancer cases and deaths from cancer were reported as 254,718 (age-standardized rate [ASR], 275.4 per 100,000) and 81,203 (ASR, 72.2 per 100,000), respectively. For the first time, lung cancer (n=29,960) became the most frequent cancer in Korea, excluding thyroid cancer. The overall cancer incidence rates increased by 3.3% annually from 1999 to 2012, and decreased by 5.3% annually from 2012 to 2015, thereafter, followed by nonsignificant changes. The incidence of thyroid cancer increased again from 2016 (annual percentage change, 6.2%). Cancer mortality rates have been decreasing since 2002, with more rapid decline in recent years (annual decrease of 2.7% from 2002 to 2013; 3.3% from 2013 to 2019). The 5-year relative survival between 2015 and 2019 was 70.7%, which contributed to prevalent cases reaching over 2 million in 2019. Cancer survival rates have improved over the past decades, but the number of newly diagnosed cancers is still increasing, with some cancers showing only marginal improvement in survival outcomes. As the number of cancer survivors increases, a comprehensive cancer control strategy should be implemented in line with the changing aspects of cancer statistics.
DOI：
10.1007/978-1-4419-0685-4_1
发表时间：
2010-01-01
期刊：
BREAST CANCER EPIDEMIOLOGY
影响因子：
--
作者：
Ferlay, Jacques;Hery, Clarisse;Sankaranarayanan, Rengaswamy
通讯作者：
Sankaranarayanan, Rengaswamy
影响因子：
4.6
作者：
Shin, Hai-Rim;Won, Young-Joo;Park, Jae-Gahb
通讯作者：
Park, Jae-Gahb